| 英文别名 |
(4S,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride;Minocycline HCL;Minocyclin HCl;(4s-(4alpha,4aalpha,5aalpha,12aalpha))-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide monohydrochloride;Minocycline hydrochloride;minocyclinehydrochloridehydrate;Minocycline;Minocycline (hydrochloride);Minocycline Hydrochl;Minocyline hydrochloride;[4S-(4alpha,4aalpha,5aalpha,12aalpha)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide monohydrochloride;minocyn;MINOCIN;Arestin;Dynacin;tri-mino;MYNOCINE;Klinomyci;Minomycin;Periofeel;Klinomycin;Minocycline chloride;Vectrin;Periocline;Minomax;Solodyn;Mynocine hydrochloride;Tri-minocycline;Minocycline, Hydrochloride;Minocycline hydrochloride (internal use);0020414E5U;MINO;DSSTox_RID_80306;DSSTox_CID_24545;DSSTox_GSID_44545;Minocyclinehydrochloride;minomycin hydrochloride;CCG-40107;NCGC00255988-01;M2288;(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamidehydrochloride;7-Dimethylamino-6-demethyl-6-deoxytetracycline, HCl;ZILXI;Tox21_301590;2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, hydrochloride (1:2), (4S,4aS,5aR,12aS)-;Acnez;Prestwick_626;MLS002548863;Minocycline (as hydrochloride);BCP06597;Q-201407;[4S-(4a,4aa,5aa,12aa)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a,tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide;CS-1256;Q27104777;NC00460;HY-17412;NSC757120;SMR001906766;EINECS 237-099-7;MINOCYCLINE HYDROCHLORIDE [MART.];PD003090;MINOCYCLINE HYDROCHLORIDE [USP MONOGRAPH];HB4617;s4226;CAS-13614-98-7;Minocycline hydrochloride, crystalline;Ximino;Minomycin chloride;NSC-141993;CHEBI:50697;HMS1568P12;Minocycline hydrochloride, United States Pharmacopeia (USP) Reference Standard;C23H27N3O7.HCl;Pharmakon1600-01500414;UNII-0020414E5U;Arestin (TN);SCHEMBL2537;NCGC00096006-01;DTXCID6024545;Dynacin (TN);Minocycline hydrochloride, European Pharmacopoeia (EP) Reference Standard;Minocycline Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material;MINOCYCLINE HYDROCHLORIDE [JAN];10118-90-8 (base);MINOCYCLINE HYDROCHLORIDE [MI];AKOS015951312;Minocycline hydrochloride (JP17/USP);SPECTRUM1500414;NSC-757120;Minocin (TN);AC-22362;AS-75306;CHEMBL4576719;Tox21_111250_1;Lederderm;Solodyn (TN);Tox21_111250;13614-98-7;4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride;MINOCYCLINE HYDROCHLORIDE [VANDF];FXFM-244;NCGC00178854-03;(4S,12aS,4aS,5aR)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4,5,6,12a,4a,5a-hexahydronaphtha... |
